-
FA Patients May Benefit From MS Therapy Dimethyl Fumarate, Study Says
Treatment with the approved multiple sclerosis therapy dimethyl fumarate may be beneficial for patients with Friedreich’s ataxia, researchers say. Read more about it here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.